WS #15333
TD Cowen upgraded MetLife to Buy with a price target of $110, while JP Morgan raised its price target for Merck & Co. to $165, maintaining an Overweight rating. These upgrades reflect analyst confidence in the healthcare and insurance sectors' ability to navigate current economic conditions. J.Jill was also upgraded to Hold with a raised price target, indicating selective strength in consumer discretionary.
Healthcare and Insurance Analyst Upgrades
TD Cowen upgraded MetLife to Buy with a price target of $110, while JP Morgan raised its price target for Merck & Co. to $165, maintaining an Overweight rating. These upgrades reflect analyst confidence in the healthcare and insurance sectors' ability to navigate current economic conditions. J.Jill was also upgraded to Hold with a raised price target, indicating selective strength in consumer discretionary.